Bjoern Jacobsen

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 2

Top Topics

Subarachnoid Hemorrhage

Clinical Evaluation

Induced Pluripotent Stem Cells

Top Venues

Clinical pharmacology and therapeutics

The Journal of neuroscience : the official journal of the Society for Neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Sara Belli, Maria Amann, Lucy Hutchinson, Laurène Pousse, Afsaneh Abdolzade-Bavil, Nicole Justies, Bjoern Jacobsen, Corinne Ploix, Eleni Tselempi, Vinko Tosevski, Hans Koll, Gabriel Schnetzler, Christophe Boetsch, Estelle Marrer-Berger
Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg-Depleting Antibody. Clinical pharmacology and therapeutics 116 (3) (2024)
Sara Belli, Maria Amann, Lucy Hutchinson, Laurène Pousse, Afsaneh Abdolzade-Bavil, Nicole Justies, Bjoern Jacobsen, Corinne Ploix, Eleni Tselempi, Vinko Tosevski, Hans Koll, Gabriel Schnetzler, Christophe Boetsch, Estelle Marrer-Berger
Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg-Depleting Antibody. Clinical pharmacology and therapeutics (2024)
Helmut Jacobsen, Laurence Ozmen, Antonello Caruso, Robert Narquizian, Hans Hilpert, Bjoern Jacobsen, Dick Terwel, An Tanghe, Bernd Bohrmann
Combined treatment with a BACE inhibitor and anti-Aβ antibody gantenerumab enhances amyloid reduction in APPLondon mice. The Journal of neuroscience : the official journal of the Society for Neuroscience 34 (35) (2014)